| Application no. and date | 17168533.2 (espacenet) (Federated) (European Patent Register), 20131015 | | Patent/reg. no. and date | DK/EP 3222616, 20190717 | | Publication date | 20170927 | | Priority no. and date | GB 201218640, 20121017, GB 201306881, 20130416 | | EP pub. no. and date |
EP 3222616 20170927 | | Effective date | | | Applicant/owner | Macrophage Pharma Limited, St. Stephens House,
Arthur Road, Windsor
Berkshire SL4 1RU, GB | | Applicant ref. no. | P81702876DK01E | | Inventor | PINTAT, Stéphane, c/o Chroma Therapeutics Ltd
Crown House
27 Old Gloucester Street
London WC1N 3AX, GB,
DAVIES, Stephen, John, c/o Chroma Therapeutics Ltd
Crown House
27 Old Gloucester Street
London WC1N 3AX, GB,
MOFFAT, David, Festus, Charles, c/o Chroma Therapeutics Ltd
Crown House
27 Old Gloucester Street
London WC1N 3AX, GB | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 31/4412 (2006.01) , A61P 29/00 (2006.01) , A61P 35/00 (2006.01) , C07D 213/73 (2006.01) | | Title | N-[2-{4-[6-amino-5-(2,4-difluorbenzoyl)-2-oxopyridin-1(2H)-yl]-3,5-difluorphenyl}ethyl]-L-alanin og terbutylester deraf | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
